Clinical Trial of the Efficacy and Safety of Raphamin in Combined Treatment of Community-acquired Pneumonia

PHASE3CompletedINTERVENTIONAL
Enrollment

370

Participants

Timeline

Start Date

December 1, 2023

Primary Completion Date

March 19, 2025

Study Completion Date

March 19, 2025

Conditions
Community-acquired PneumoniaPneumonia
Interventions
DRUG

Raphamin

Tablet for oral use.

DRUG

Placebo

Tablet for oral use.

Trial Locations (38)

111123

Central Research Institute of Epidemiology, Moscow

119991

First Moscow State Medical University named after I.M. Sechenov, Moscow

129110

Moscow Regional Research Clinical Institute named after. M.F. Vladimirsky, Moscow

150030

Clinical Hospital # 2, Yaroslavl

150040

"LLC Medical Center for Diagnostics and Prevention Plus", Yaroslavl

152155

Rostov Central District Hospital, Rostov

153025

Ivanovo Clinical Hospital named after Kuvayevs, Ivanovo

163000

Northern Medical Clinical Center named after N.A. Semashko Federal Medical and Biological Agency, Arkhangelsk

188300

Gatchina Clinical Interdistrict Hospital, Gatchina

191036

St. Petersburg Research Institute of Phthisiopulmonology, Saint Petersburg

194156

"LLC Energy of Health", Saint Petersburg

194354

"LLC Medical center Reavita Med SPb", Saint Petersburg

194356

"LLC Medical Clinic", Saint Petersburg

195427

City Polyclinic # 112, Saint Petersburg

196158

"LLC Zvezdnaya Clinic", Saint Petersburg

198510

Nikolaevskaya hospital, Petergof

199106

City Pokrovskaya Hospital, Saint Petersburg

199178

City Polyclinic # 4, Saint Petersburg

199406

"LLC Meili", Saint Petersburg

214019

Smolensk State Medical University, Smolensk

236005

Central City Clinical Hospital, Kaliningrad

350063

Kuban State Medical University/Department of Infectious Diseases and Phthisiopulmonology, Krasnodar

355000

"LLC Scientific Medical Center of General Therapy and Pharmacology", Stavropol

357502

"LLC 4D Ultrasound Clinic", Pyatigorsk

394066

Voronezh Regional Clinical Hospital # 1, Voronezh

420012

Kazan State Medical University/Department of Infectious Diseases, Kazan'

Kazan State Medical University, Kazan'

426063

City Clinical Hospital # 9 of the Ministry of Health of the Udmurt Republic, Izhevsk

432017

Ulyanovsk Regional Clinical Hospital, Ulyanovsk

440067

Clinical Hospital # 4, Penza

443001

"Medical University Reaviz", Samara

443099

Samara State Medical University/Department of General and Clinical Microbiology, Immunology and Allergology, Samara

450008

Bashkir State Medical University/Department of Internal Medicine, Ufa

600023

Regional Clinic Hospital, Vladimir

603093

Nizhny Novgorod Regional Clinical Hospital named after N.A. Semashko, Nizhny Novgorod

603155

"LLC Persona group of companies", Nizhny Novgorod

614070

"LLC Professor's clinic", Perm

624002

Aramil city hospital, Aramil

Sponsors
All Listed Sponsors
lead

Materia Medica Holding

INDUSTRY

NCT06263881 - Clinical Trial of the Efficacy and Safety of Raphamin in Combined Treatment of Community-acquired Pneumonia | Biotech Hunter | Biotech Hunter